Open-label Study of Liothyronine in MS

NCT02506751 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Multiple Sclerosis, Relapsing-Remitting
Multiple Sclerosis, Secondary Progressive
Multiple Sclerosis, Primary Progressive

Interventions

DRUG: liothyronine

Sponsor

Johns Hopkins University